Kanagawa, Japan

Haruyuki Nishida

This inventor holds 1 USPTO granted patent. Top assignee: Prism Biolab Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haruyuki Nishida. Retrieved from https://idiyas.com/inventor/haruyuki-nishida-d0fh68uw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haruyuki Nishida and His Work in Cancer Research

Introduction

Haruyuki Nishida is an inventor associated with Kanagawa, Japan, and Prism Biolab Corporation. His listed patent work concerns a heterocyclic compound with potential activity against cancer cell proliferation.

Latest Patents

Nishida is associated with 1 patent, titled “Heterocyclic compounds.” The patent describes a compound of formula (I), with its symbols defined in the description, or a pharmaceutically acceptable salt thereof. The disclosed compound is reported to have superior inhibitory activity on cancer cell proliferation.

Career Highlights

Nishida’s listed invention reflects research into compounds that may inhibit cancer cell growth. The available information identifies Prism Biolab Corporation as his company affiliation.

Collaborations

Nishida’s listed coworkers include Hajime Takashima and Eiji Honda.

Conclusion

Haruyuki Nishida’s patent work centers on a heterocyclic compound with reported cancer cell proliferation-inhibiting activity, developed in connection with Prism Biolab Corporation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…